Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Veronique Dieras
Based on 73 articles published since 2009
(Why 73 articles?)
||||
Expertise Level
The expertise of Veronique Dieras ranks in the
  • Top 0.03%
  • ... of 264,224 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 73 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Diéras, Veronique   ·   Diéras, V   ·   Diéras, Véronique   ·   Dieras, V   ·   Dieras, Véronique   ·   Dieras, Veronique
Work Locations
Details
Most likely:    Institut Curie      
2019
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, 2nd Floor, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Republican Clinical Oncology Dispensary, State Budget Medical Institution, Ufa, Russia. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), Munich, Germany. · Breast Cancer Center, Memorial Cancer Institute, Hollywood, FL, USA. · Patient and Health Impact, Pfizer Inc, New York, NY, USA. · Clinical Statistics, Pfizer Inc, La Jolla, CA, USA. · Global Product Development, Clinical, Pfizer S.r.l, Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA, USA. · Global Product Development, Clinical, Pfizer Inc, Collegeville, PA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 30632023
2018
  • Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest-René Gauducheau, Nantes, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Centre Rene Huguenin-Institut Curie, St Cloud, France. · Bexon Clinical Consulting, Upper Montclair, NJ, United States of America. · Invivis Pharmaceuticals, Bridgewater, NJ, United States of America. · Arno Therapeutics, Flemington, NJ, United States of America. · Pubmed 30304013
  • Department of Surgery, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. · Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Tours, France. · Department of Oncology, Centre Leon Berard, 28 Prom. Léa et Napoléon Bullukian, 69008, Lyon, France. · Department of Oncology, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. · Department of Oncology, Institut Curie, Hôpital Claudius Regaud, 26 Rue d'Ulm, 75005, Paris, France. · Department of Neurology Mazarin, Groupe Hospitalier Pitié Salpétrière, 47 bd del'hôpital, 75013, Paris, France; Assistance Publique des Hôpitaux de Paris, Paris, France; Université Pierre et Marie Curie, Paris VI, Paris, France. · Department of Clinical Research, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. · Department of Epidemiology, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France. · Department of Oncology, Clinique de La Porte Verte, 6 Avenue Maréchal Franchet D'Esperey, 78004, Versailles, France. · Lille University, Inserm U1192 PRISM, Villeneuve d'Ascq, France; Breast unit, Department of Medical Oncology, Oscar Lambret Center, 3 Rue Frédéric Combemale, 59000, Lille, France; Neuro-oncology, Department of Neurosurgery, University Hospital, Lille, France. · Department of Oncology, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. Electronic address: · Pubmed 29635147
  • Toby Robins Breast Cancer Research Centre, Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Department of Medicine, David Geffen School of Medicine, Los Angeles, USA. · Department of Medicine, Hospital Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Department of Medicine, University of Pennsylvania, Philadelphia, USA. · Klinik und Poliklinik fuer Frauenheilkunde Klinikum Rechts der Isar, Technische Universitaet Muenchen, Munich, Germany. · Department of Clinical Research, Institut Curie, Paris, France. · Department of Breast Medical Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, USA. · State Budget Medical Institution Republican Clinical Oncology Dispensary, Ufa, Russia. · European Institute of Oncology, Milan, Italy. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago. · Pfizer Inc, La Jolla, USA. · Pfizer S.r.l, Milan, Italy. · Pfizer Inc, New York, USA. · Department of Medical Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, Canada. · Pubmed 29342248
  • Moffitt Cancer Center, Tampa, USA. · Institut Curie, Paris, France, USA. · Weill Cornell Medical College, New York, USA. · Masarykuv Onkologický Ústav, Brno, Czech Republic, Durham, USA. · Duke University, Durham, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Dnepropetrovsk Medical Academy, City Hospital #4, Dnipro, Ukraine. · Midwestern Regional Medical Center, Zion, USA. · Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Stanford University School of Medicine, Stanford, USA. · University of Pennsylvania, Philadelphia, USA. · Prince of Wales Hospital, Sydney, Australia. · Sheba Medical Center, Tel Hashomer, Israel. · Dana-Farber Cancer Institute, Boston, USA. · Chemotherapy Department, Lviv State Regional Treatment and Diagnostics Oncology Center, Lviv, Ukraine. · Department of Clinical Oncology, Oncology Centre, Bydgoszcz, UMK, Torun, Poland. · Department of Oncology, Vejle Hospital/Lillebaelt Hospital, Vejle, Denmark. · Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, USA. · Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA. · AbbVie Inc., North Chicago, USA. · Massachusetts General Hospital, Boston, USA. · University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Pubmed 29045554
  • Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005 Paris & Saint-Cloud, France. · Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié, 229 Cours de L'Argonne, 33000 Bordeaux, France. · Department of Medical Oncology, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298 Montpellier, France. · Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont Ferrand, France. · Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059 Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes & Angers, 15 rue André Boquel, 49055 Angers, France. · Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189 Nice, France. · Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000 Caen, France. · Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079 Dijon, France. · Medical Oncology Department, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000 Lille, France. · Medical Oncology Department, Centre Eugéne Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000 Rennes, France. · INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Center, F-33000 Bordeaux, France. · Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000 Strasbourg, France. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100 Reims, France. · Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. · Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000 Rouen, France. · Department of BioPathology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654 Paris, France. · Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 29660596
  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France. · Department of Medical Oncology, Institut Curie, Paris, France. · University Hospital Jean Minjoz, INSERM, Besançon, France. · Institut Curie-Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius-Regaud, IUCT-oncopole, Université Paul-Sabatier, Toulouse, France. · Department of Clinical Research and Innovation, Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France. · Pubmed 29281873
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Department of Medical Oncology, Institut Curie, Paris, France. Electronic address: · Mount Vernon Cancer Centre, Northwood, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Stanford Cancer Institute, Palo Alto, CA, USA. · Medical Office Hematology, Aschaffenburg, Germany. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Duke University Medical Center, Durham, NC, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · San Raffaele Hospital, Milan, Italy. · Pubmed 28526536
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St., Dublin, 7, Ireland. · Division of Early Drug Development, Istituto Europeo di Oncologia, Milan, Italy. · Clinical Investigational Unit, Institut Curie, Paris, France. · Breast UnitKliniken Essen-Mitte, Essen, Germany. · Department of Obstetrics & Gynecology, St.-Johannes-Hospital, Dortmund, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-EMN, Erlangen, Germany. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Centre Leon Berard, Lyon, France. · Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Department of Clinical Oncology, Nottingham University Hospital NHS Trust (City campus), Nottingham, UK. · Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. · Division of Hematology/Oncology, University of Tennessee Health Science Center, The West Clinic, Medical Oncology, Memphis, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · MGH Cancer Center, Massachusetts General Hospital, Boston, USA. · Pubmed 28176175
  • Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. · Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA. · Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA 19104, USA. · Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, NSW 2031, Australia. · Department of General Oncology, Chaim Sheba Medical Center, Ramat Gan 52 621, Israel. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. · Department of Medical Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA. · Department of Medical Oncology, Institut Curie, Paris 75248, France. · The Center for Women's Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · AbbVie Inc., Chicago, IL 60064, USA. · Pubmed 27739325
  • Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Institut Curie, Unit of Biometry, PSL Research University, INSERM U900, Paris, France. · Department of Anesthesiology, Institut Curie, PSL Research University, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 28779538
  • Centre Antoine Lacassagne, Nice, France. · CHU de Nîmes, Nîmes, France. · Aix-Marseille University, INSERM UMR S910, GMGF, Marseille, France. · APHM Hôpital Timone, Laboratoire de Génétique Moléculaire, Marseille, France. · Faculté de Pharmacie de Montpellier, Montpellier, France. · Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam,The Netherlands. · Institut de Cancérologie de l'Ouest, MMS EA 2160, Université de Nantes, Nantes, France. · Institut Claudius-Regaud, CRCT, Université de Toulouse, Inserm, UPS, Toulouse, France. · Institut de Cancérologie de Lorraine, UMR CNRS 7039 CRAN, Université de Lorraine, Nancy, France. · Centre Paul Lamarque, Montpellier, France. · CHU de Besançon, Besançon, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Paris, France. · Centre Azuréen de Cancérologie, Mougins, France. · CHU de Grenoble, Grenoble, France. · Institut Paoli Calmettes, Marseille, France. · Centre Oscar Lambret, Lille, France. · Polyclinique Nord Aquitaine, Bordeaux, France. · Pubmed 28481884
  • Department of radiation oncology, institut Curie, 26, rue d'Ulm, 75005 Paris, France. Electronic address: · Department of radiation oncology, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Department of medical oncology, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Pubmed 28347625
  • Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France · Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France. · Biostatistics Unit, Curie Institute, PSL Research University, Paris, France. · INSERM U900, Curie Institute, PSL Research University, Paris, France. · Pharmacy Department, Curie Institute, PSL Research University, Paris, France. · Descartes University Paris, Paris, France. · Pubmed 28314310
  • Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. Electronic address: · Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. · Pubmed 28126188
  • Service de Médecine Nucléaire, Institut Curie, Paris, France · Service de Médecine Nucléaire, Institut Curie, Saint-Cloud, France. · Faculté de Médecine, Université Versailles Saint-Quentin, Versailles, France. · Département d'Oncologie Médicale, Institut Curie, Paris, France; and. · Faculté de Médecine, Université Paris-Descartes, Paris, France. · Service de Médecine Nucléaire, Institut Curie, Paris, France. · Pubmed 27587709
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • Genetics Department, Institut Curie, PSL Research University, Paris, France. · Faculty of Pharmacy, Aleppo University, Aleppo, Syria. · Translational Research Department, Institut Curie, PSL Research University, Paris, France. · BioPôle Alfort, National Veterinary School of Alfort, Maisons Alfort, France. · INRA, PHASE Department, Paris, France. · Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Surgery Department, Institut Curie, PSL Research University, Paris, France. · AstraZeneca R&D Cambr idge, CRUK Cambridge Institute, Cambridge, UK. · EA7331, University of Paris Descartes, Paris, France. · Pubmed 27374081
  • Genetics Department, Hospital, Institut Curie, Paris, 75005, France. · Faculty of Pharmacy, Aleppo University, Aleppo, Syria. · Translational Research Department, Institut Curie, Paris, 75005, France. · BioPôle Alfort, National Veterinary School of Alfort, 7, Av. Du Général De Gaulle, 94704, Maisons Alfort, France. · PHASE Department, INRA, Nouzilly, France. · Medical Oncology Department, Institut Curie, Paris, 75005, France. · Pubmed 26686064
2015
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Department of Clinical Research, Institut Curie Paris & Saint Cloud, Paris · Centre René Gauducheau, Centre Régional de Lutte Contre le Cancer (CRLC) Nantes, Atlantique, France. · Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, USA. · Institut du Cancer de Montpellier (ICM), Montpellier, France. · The University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · Genentech, Inc., South San Francisco, USA. · Roche Product Development, Shanghai, China. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 26202594
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Department of Medical Oncology, Institut Curie, Paris, France. · Department of Clinical Research, Institut Curie, Paris, France; INSERM U900, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France; Department of Clinical Research, Institut Curie, Paris, France. · Department of Radiology, Institut Curie, Paris, France. · Department of Supportive Care, Institut Curie, Paris, France. · Department of Clinical Research, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France; Circulating Tumor Biomarkers Laboratory, SIRIC, Institut Curie, Paris, France; University Paris Descartes, Paris, France. Electronic address: · Department of Medical Oncology, Institut Curie, Paris, France; Circulating Tumor Biomarkers Laboratory, SIRIC, Institut Curie, Paris, France. · Pubmed 25700777
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, Duke University Medical Center, Durham. · Product Development, Oncology, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology and Breast Centre, Cantonal Hospital, St Gallen, Switzerland. · Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Biostatistics, Genentech, Inc., South San Francisco, USA. · Hematology, Medical Office, Aschaffenburg, Germany. · Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 25355722
  • Departments of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. · Departments of Medical Oncology, Institut Bergonié, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Departments of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Pubmed 26387602
2014
  • Department of Clinical Research, Institut Curie, Paris, France, · Pubmed 23852665
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Laboratory of preclinical investigation, Translational Research Department, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France; INSERM U900, Paris, France. · Department of Genetics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Translational Research Department, Institut Curie, Paris, France. · AbbVie Biotherapeutics, Redwood City, California, United States of America. · Department of Oncogenetic, Institut Curie, Paris, France. · Laboratory of preclinical investigation, Translational Research Department, Institut Curie, Paris, France; Department of Oncogenetic, Institut Curie, Paris, France. · Pubmed 25375638
  • Véronique Diéras, Institut Curie, Paris, France · Nadia Harbeck, University of Munich, Munich, Germany · G. Thomas Budd, Cleveland Clinic, Lerner College of Medicine, Cleveland, OH · Joel K. Greenson, University of Michigan, Ann Arbor, MI · Ellie A. Guardino, Meghna Samant, Nataliya Chernyukhin, and Melanie C. Smitt, Genentech, South San Francisco, CA · and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25024070
2011
  • Institut Curie, département d'oncologie médicale, unité d'investigation clinique, 25, rue d'Ulm, 75248 Paris Cedex 05, France. · Pubmed 21527366
2014
  • Authors' Affiliations: Research Oncology, Departments of Biostatistics, Product Development Oncology, and Translational Oncology, Genentech, Inc., South San Francisco, California; Indiana University Simon Cancer Center, Indianapolis, Indiana; Institute Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Curie, Paris, France; Sarah Cannon Research Institute, Nashville, Tennessee; Loyola University Medical Center, Maywood, Illinois; University of Munich, Munich, Germany; and Division of Medical Oncology, Centro di Riferimento Oncologico, Instituto Nazionale Tumori Aviano, Italy. · Pubmed 24097864
2013
  • Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005, Paris, France, · Pubmed 24043602
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23526930
2012
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 21907436
  • Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 21642515
  • Département de chirurgie, Institut Curie, Paris, France. · Pubmed 22529987
  • Department of Medical Oncology, Institut Curie, 26 rue d’Ulm, Paris Cedex 05, France. · Pubmed 21358298
2011
  • Institut Curie, département d’oncologie-radiothérapie, 26, rue d’Ulm, 75005 Paris, France. · Pubmed 21527365
  • Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. · Pubmed 21543285
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 20932686
  • Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 20924076
Probable:    Miscellaneous institutions in Rennes      
2019
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, 2nd Floor, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Republican Clinical Oncology Dispensary, State Budget Medical Institution, Ufa, Russia. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), Munich, Germany. · Breast Cancer Center, Memorial Cancer Institute, Hollywood, FL, USA. · Patient and Health Impact, Pfizer Inc, New York, NY, USA. · Clinical Statistics, Pfizer Inc, La Jolla, CA, USA. · Global Product Development, Clinical, Pfizer S.r.l, Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA, USA. · Global Product Development, Clinical, Pfizer Inc, Collegeville, PA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 30632023
2018
  • Department of Medical Oncology, Acıbadem University School of Medicine, Istanbul, Turkey. Electronic address: · Cancer Research UK Clinical Centre, St James' University Hospital, Leeds, UK. Electronic address: · Center Eugène Marquis, Rennes, France. Electronic address: · Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 29329006
Probable:    Miscellaneous institutions in Paris      
2018
  • National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. · Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany. · Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain. · Rigshospitalet, Copenhagen, Denmark. · Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Institute Curie, Paris, France. · Department of Medical Oncology, Biomedical Health Research Institute INCLIVA, University of Valencia, Valencia and CIBERONC, Institute of Health Carlos III, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. · Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France. · Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland. · Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany. · Pharma Research and Early Development (pRED), Roche Innovation Center Welwyn, Welwyn Garden City, UK. · A4P Consulting Ltd, Sandwich, UK. · Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany. · Pubmed 29349598
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 73 total) written by Veronique Dieras about Breast Neoplasms:

  • Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. 2019
  • Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer. 2018
  • Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. 2018
  • Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers. 2018
  • Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis. 2018
  • Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer. 2018
  • Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases. 2018
  • Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with BRCA1/2 locally recurrent/metastatic breast cancer: randomized phase II study. 2018
  • Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. 2018
  • Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer. 2018
Show List of Full Article Records
Google Searches

Learn more about Veronique Dieras using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Institut Curie
Miscellaneous institutions in Rennes
Miscellaneous institutions in Paris
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Institut Curie
2019
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, 2nd Floor, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Republican Clinical Oncology Dispensary, State Budget Medical Institution, Ufa, Russia. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), Munich, Germany. · Breast Cancer Center, Memorial Cancer Institute, Hollywood, FL, USA. · Patient and Health Impact, Pfizer Inc, New York, NY, USA. · Clinical Statistics, Pfizer Inc, La Jolla, CA, USA. · Global Product Development, Clinical, Pfizer S.r.l, Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA, USA. · Global Product Development, Clinical, Pfizer Inc, Collegeville, PA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 30632023
2018
  • Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest-René Gauducheau, Nantes, France. · Department of Medical Oncology, Institut Bergonié, Bordeaux, France. · Department of Medical Oncology, Centre Rene Huguenin-Institut Curie, St Cloud, France. · Bexon Clinical Consulting, Upper Montclair, NJ, United States of America. · Invivis Pharmaceuticals, Bridgewater, NJ, United States of America. · Arno Therapeutics, Flemington, NJ, United States of America. · Pubmed 30304013
  • Department of Surgery, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. · Université François-Rabelais de Tours, CNRS, GICC UMR 7292, CHRU de Tours, Service de Pharmacologie-Toxicologie, Tours, France. · Department of Oncology, Centre Leon Berard, 28 Prom. Léa et Napoléon Bullukian, 69008, Lyon, France. · Department of Oncology, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. · Department of Oncology, Institut Curie, Hôpital Claudius Regaud, 26 Rue d'Ulm, 75005, Paris, France. · Department of Neurology Mazarin, Groupe Hospitalier Pitié Salpétrière, 47 bd del'hôpital, 75013, Paris, France; Assistance Publique des Hôpitaux de Paris, Paris, France; Université Pierre et Marie Curie, Paris VI, Paris, France. · Department of Clinical Research, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. · Department of Epidemiology, Institut Curie, 26 Rue d'Ulm, 75005, Paris, France. · Department of Oncology, Clinique de La Porte Verte, 6 Avenue Maréchal Franchet D'Esperey, 78004, Versailles, France. · Lille University, Inserm U1192 PRISM, Villeneuve d'Ascq, France; Breast unit, Department of Medical Oncology, Oscar Lambret Center, 3 Rue Frédéric Combemale, 59000, Lille, France; Neuro-oncology, Department of Neurosurgery, University Hospital, Lille, France. · Department of Oncology, Institut Curie, Hôpital René Huguenin, 35 Rue Dailly, 92210, Saint Cloud, France. Electronic address: · Pubmed 29635147
  • Toby Robins Breast Cancer Research Centre, Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Department of Medicine, David Geffen School of Medicine, Los Angeles, USA. · Department of Medicine, Hospital Gregorio Marañón, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Department of Medicine, University of Pennsylvania, Philadelphia, USA. · Klinik und Poliklinik fuer Frauenheilkunde Klinikum Rechts der Isar, Technische Universitaet Muenchen, Munich, Germany. · Department of Clinical Research, Institut Curie, Paris, France. · Department of Breast Medical Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, USA. · State Budget Medical Institution Republican Clinical Oncology Dispensary, Ufa, Russia. · European Institute of Oncology, Milan, Italy. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago. · Pfizer Inc, La Jolla, USA. · Pfizer S.r.l, Milan, Italy. · Pfizer Inc, New York, USA. · Department of Medical Oncology, British Columbia Cancer Agency-Vancouver Centre, Vancouver, Canada. · Pubmed 29342248
  • Moffitt Cancer Center, Tampa, USA. · Institut Curie, Paris, France, USA. · Weill Cornell Medical College, New York, USA. · Masarykuv Onkologický Ústav, Brno, Czech Republic, Durham, USA. · Duke University, Durham, USA. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Dnepropetrovsk Medical Academy, City Hospital #4, Dnipro, Ukraine. · Midwestern Regional Medical Center, Zion, USA. · Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Stanford University School of Medicine, Stanford, USA. · University of Pennsylvania, Philadelphia, USA. · Prince of Wales Hospital, Sydney, Australia. · Sheba Medical Center, Tel Hashomer, Israel. · Dana-Farber Cancer Institute, Boston, USA. · Chemotherapy Department, Lviv State Regional Treatment and Diagnostics Oncology Center, Lviv, Ukraine. · Department of Clinical Oncology, Oncology Centre, Bydgoszcz, UMK, Torun, Poland. · Department of Oncology, Vejle Hospital/Lillebaelt Hospital, Vejle, Denmark. · Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, USA. · Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA. · AbbVie Inc., North Chicago, USA. · Massachusetts General Hospital, Boston, USA. · University of Pittsburgh Cancer Institute, Pittsburgh, USA. · Pubmed 29045554
  • Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Biostatistics, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005 Paris & Saint-Cloud, France. · Department of Medical Oncology, Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, 69008 Lyon, France. · Department of Medical Oncology, Institut Bergonié, 229 Cours de L'Argonne, 33000 Bordeaux, France. · Department of Medical Oncology, Institut Du Cancer de Montpellier, 208 Rue des Apothicaires, 34298 Montpellier, France. · Department of Medical Oncology, Centre Jean Perrin, 58 Rue Montalembert, 63011 Clermont Ferrand, France. · Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, 13009 Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud - IUCT Oncopole, 1 Avenue Irène-Joliot-Curie, 31059 Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest Nantes & Angers, 15 rue André Boquel, 49055 Angers, France. · Department of Medical Oncology, Centre Antoine Lacassagne, 33 Avenue de Valambrose, 06189 Nice, France. · Department of Medical Oncology, Centre François Baclesse, 3 Avenue du Général Harris, 14000 Caen, France. · Department of Medical Oncology, Centre Georges François Leclerc, 1 rue Professeur Marion, 21079 Dijon, France. · Medical Oncology Department, Centre Oscar Lambret, 3 Rue Frédéric Combemale, 59000 Lille, France. · Medical Oncology Department, Centre Eugéne Marquis, Avenue de la Bataille Flandres-Dunkerque, 35000 Rennes, France. · INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Center, F-33000 Bordeaux, France. · Department of Medical Oncology, Centre Paul Strauss, 3 Rue de la Porte de l'Hôpital, 67000 Strasbourg, France. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, 1 Rue du Général Koenig, 51100 Reims, France. · Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, 6 Avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France. · Department of Medical Oncology, Centre Henri Becquerel, Rue d'Amiens, 76000 Rouen, France. · Department of BioPathology, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. · Department of Research and Development, R&D Unicancer, 101 Rue de Tolbiac, 75654 Paris, France. · Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · Pubmed 29660596
  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France. · Department of Medical Oncology, Institut Curie, Paris, France. · University Hospital Jean Minjoz, INSERM, Besançon, France. · Institut Curie-Hôpital René Huguenin, Saint-Cloud, France. · Institut Claudius-Regaud, IUCT-oncopole, Université Paul-Sabatier, Toulouse, France. · Department of Clinical Research and Innovation, Biostatistics Unit, Institut Paoli-Calmettes, Marseille, France. · Aix Marseille University, INSERM, IRD, SESSTIM, Marseille, France. · Pubmed 29281873
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Memorial Sloan Kettering Cancer Center, New York, New York. · Dana-Farber Cancer Institute, Boston, Massachusetts. · University of California San Francisco Comprehensive Cancer Center, San Francisco, California. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Ramón y Cajal University Hospital, Madrid, Spain. · Institut Curie, Paris, France. · Texas Oncology, Austin, Texas. · Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, Texas. · Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium. · Memorial Sloan Kettering Cancer Center, New York, New York. · Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, Tennessee. · Eli Lilly and Company, Indianapolis, Indiana. · Pubmed 28533223
  • Department of Medical Oncology, Institut Curie, Paris, France. Electronic address: · Mount Vernon Cancer Centre, Northwood, UK. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada. · Stanford Cancer Institute, Palo Alto, CA, USA. · Medical Office Hematology, Aschaffenburg, Germany. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Duke University Medical Center, Durham, NC, USA. · F Hoffmann-La Roche, Basel, Switzerland. · Genentech Inc, South San Francisco, CA, USA. · San Raffaele Hospital, Milan, Italy. · Pubmed 28526536
  • Leeds Institute of Cancer and Pathology and St James's Institute of Oncology, Leeds, UK. Electronic address: · Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Baylor-Sammons Cancer Center, Texas Oncology, U.S. Oncology, Dallas, TX, USA. · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Mayo Clinic, Jacksonville, FL, USA. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota, Department of Medicine, Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Ramon y Cajal University Hospital, Madrid, Spain. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Consultant, Sebastopol, CA, USA. · University of California, San Francisco, CA, USA. · Pubmed 28360015
  • Department of Medical Oncology, Mater Misericordiae University Hospital, Eccles St., Dublin, 7, Ireland. · Division of Early Drug Development, Istituto Europeo di Oncologia, Milan, Italy. · Clinical Investigational Unit, Institut Curie, Paris, France. · Breast UnitKliniken Essen-Mitte, Essen, Germany. · Department of Obstetrics & Gynecology, St.-Johannes-Hospital, Dortmund, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-EMN, Erlangen, Germany. · Service d'Oncologie Médicale, Institut de Cancérologie de l'Ouest, Saint Herblain, France. · Department of Medical Oncology, Centre Leon Berard, Lyon, France. · Petrov Research Institute of Oncology, St. Petersburg, Russian Federation. · Department of Clinical Oncology, Nottingham University Hospital NHS Trust (City campus), Nottingham, UK. · Unit of Medical Oncology, Santa Chiara Hospital, Trento, Italy. · Division of Hematology/Oncology, University of Tennessee Health Science Center, The West Clinic, Medical Oncology, Memphis, USA. · GSK Vaccines, Rixensart, Belgium. · Celyad, Mont-Saint-Guibert, Belgium. · MGH Cancer Center, Massachusetts General Hospital, Boston, USA. · Pubmed 28176175
  • Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. · Department of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA. · Basser Center for BRCA, University of Pennsylvania, Philadelphia, PA 19104, USA. · Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, NSW 2031, Australia. · Department of General Oncology, Chaim Sheba Medical Center, Ramat Gan 52 621, Israel. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. · Department of Medical Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA. · Department of Medical Oncology, Institut Curie, Paris 75248, France. · The Center for Women's Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · AbbVie Inc., Chicago, IL 60064, USA. · Pubmed 27739325
  • Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Institut Curie, Unit of Biometry, PSL Research University, INSERM U900, Paris, France. · Department of Anesthesiology, Institut Curie, PSL Research University, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 28779538
  • Centre Antoine Lacassagne, Nice, France. · CHU de Nîmes, Nîmes, France. · Aix-Marseille University, INSERM UMR S910, GMGF, Marseille, France. · APHM Hôpital Timone, Laboratoire de Génétique Moléculaire, Marseille, France. · Faculté de Pharmacie de Montpellier, Montpellier, France. · Laboratory Genetic Metabolic Diseases, Academic Medical Center, Amsterdam,The Netherlands. · Institut de Cancérologie de l'Ouest, MMS EA 2160, Université de Nantes, Nantes, France. · Institut Claudius-Regaud, CRCT, Université de Toulouse, Inserm, UPS, Toulouse, France. · Institut de Cancérologie de Lorraine, UMR CNRS 7039 CRAN, Université de Lorraine, Nancy, France. · Centre Paul Lamarque, Montpellier, France. · CHU de Besançon, Besançon, France. · Centre Léon Bérard, Lyon, France. · Institut Curie, Paris, France. · Centre Azuréen de Cancérologie, Mougins, France. · CHU de Grenoble, Grenoble, France. · Institut Paoli Calmettes, Marseille, France. · Centre Oscar Lambret, Lille, France. · Polyclinique Nord Aquitaine, Bordeaux, France. · Pubmed 28481884
  • Department of radiation oncology, institut Curie, 26, rue d'Ulm, 75005 Paris, France. Electronic address: · Department of radiation oncology, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Department of medical oncology, institut Curie, 26, rue d'Ulm, 75005 Paris, France. · Pubmed 28347625
  • Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France · Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France. · Biostatistics Unit, Curie Institute, PSL Research University, Paris, France. · INSERM U900, Curie Institute, PSL Research University, Paris, France. · Pharmacy Department, Curie Institute, PSL Research University, Paris, France. · Descartes University Paris, Paris, France. · Pubmed 28314310
  • Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. Electronic address: · Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. · Pubmed 28126188
  • Service de Médecine Nucléaire, Institut Curie, Paris, France · Service de Médecine Nucléaire, Institut Curie, Saint-Cloud, France. · Faculté de Médecine, Université Versailles Saint-Quentin, Versailles, France. · Département d'Oncologie Médicale, Institut Curie, Paris, France; and. · Faculté de Médecine, Université Paris-Descartes, Paris, France. · Service de Médecine Nucléaire, Institut Curie, Paris, France. · Pubmed 27587709
2016
  • Martine Piccart-Gebhart, Université Libre de Bruxelles, Brussels, Belgium · Eileen Holmes, Eleanor McFadden, and Andrew P. Holmes, Frontier Science (Scotland), Kincraig, Kingussie, United Kingdom · José Baselga, Memorial Sloan Kettering Cancer Center, New York, NY · Evandro de Azambuja, Institut Jules Bordet, Brussels, Belgium · Evandro de Azambuja and Stella Dolci, Breast European Adjuvant Study Team, Brussels, Belgium · Amylou C. Dueck and Anne E. McCullough, Mayo Clinic, Scottsdale, AZ · Giuseppe Viale, University of Milan, Milan, Italy · Giuseppe Viale and Aron Goldhirsch, Istituto Europeo di Oncologia, Milan, Italy · Jo Anne Zujewski, National Cancer Institute, Bethesda, MD · Aron Goldhirsch, Ospedale Regionale di Lugano, Viganello-Lugano, Switzerland · Alison Armour, GlaxoSmithKline, Collegeville, PA · Kathleen I. Pritchard, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada · Kathleen I. Pritchard, University of Toronto, Toronto, Ontario, Canada · Liu Tonghua, Peking Union Medical College Hospital, Beijing, People's Republic of China · Liu Tonghua and Binghe Xu, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China · Holger Eidtmann, University Hospital Kiel, Kiel, Germany · Phuong Dinh, Breast International Group, Brussels, Belgium · Serena Di Cosimo, Istituto Nazionale del Tumori, Milan, Italy · Serena Di Cosimo, SOLTI Breast Cancer Research Group, Barcelona, Spain · Nadia Harbeck, Frauenklinik der Universität München, Munich, Germany · Sergei Tjulandin, Blokhin Russian Cancer Research Center of RAMS, Moscow, Russia · Young-Hyuck Im, Korean Cancer Study Group, Seoul, South Korea · Young-Hyuck Im, Samsung Medical Center, Seoul, South Korea · Chiun-Shen Huang, National Taiwan University Hospital, Taipei, Republic of China · Véronique Diéras, Institut Curie, Paris, France · David W. Hillman, Mayo Clinic, Rochester, MN · Antonio C. Wolff, The Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD · Christian Jackisch, Klinikum Offenba · Pubmed 26598744
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France. · Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · R&D UNICANCER, Paris, France. · Bioinformatics core facility, Gustave Roussy, Villejuif, France. · Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France. · Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. · Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Department of Clinical Research, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France. · Department of Medical Oncology, Centre Henri Becquerel, Rouen, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Pubmed 28027327
  • INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. · Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. · Bioinformatics Core Facility, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France. · R&D, UNICANCER, Paris, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Drug Development Department (DITEP), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Department of Medical Biology and Pathology, Translational Research Laboratory and BioBank, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. Faculté de Médecine, Kremlin-Bicêtre, Université Paris Sud, France. Department of Medical Oncology, Gustave Roussy, Villejuif, France. · INSERM Unit U981, Gustave Roussy, Villejuif, France. · Pubmed 27535334
  • Genetics Department, Institut Curie, PSL Research University, Paris, France. · Faculty of Pharmacy, Aleppo University, Aleppo, Syria. · Translational Research Department, Institut Curie, PSL Research University, Paris, France. · BioPôle Alfort, National Veterinary School of Alfort, Maisons Alfort, France. · INRA, PHASE Department, Paris, France. · Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Surgery Department, Institut Curie, PSL Research University, Paris, France. · AstraZeneca R&D Cambr idge, CRUK Cambridge Institute, Cambridge, UK. · EA7331, University of Paris Descartes, Paris, France. · Pubmed 27374081
  • Genetics Department, Hospital, Institut Curie, Paris, 75005, France. · Faculty of Pharmacy, Aleppo University, Aleppo, Syria. · Translational Research Department, Institut Curie, Paris, 75005, France. · BioPôle Alfort, National Veterinary School of Alfort, 7, Av. Du Général De Gaulle, 94704, Maisons Alfort, France. · PHASE Department, INRA, Nouzilly, France. · Medical Oncology Department, Institut Curie, Paris, 75005, France. · Pubmed 26686064
2015
  • Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. Electronic address: · European Institute of Oncology, Division of Medical Oncology, Milan, Italy. · Department of Clinical Research, Institut Curie, Paris, France. · Sandro Pitigliani Department of Medical Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Research UK, London Research Institute, London, UK. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Breakthrough Breast Cancer Research Centre, Institute of Cancer Research and Kings College London School of Medicine, London, UK. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 25840656
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain and Ramon y Cajal University Hospital, Madrid, Spain. Electronic address: · Institut Curie, Paris, France. · National Cancer Center, Goyang-si, Republic of Korea. · Centre Antoine Lacassagne, Nice, France. · Centre Léon Bérard, Lyon, France. · University of California, Los Angeles, CA, USA. · Centre Oscar Lambret, Lille, France; University Hospital, Lille, France. · Hôpital Saint-Louis, Paris, France. · Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. · National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. · Severance Hospital, Sinchon-dong, Seodaemun-gu, Seoul, South Korea. · Centre Jean Perrin, Clermont-Ferrand, France. · Tampere University Hospital and University of Tampere, Tampere, Finland. · Sansum Clinic, Santa Barbara, CA, USA. · Università di Modena e Reggio Emilia, Modena, Italy. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Comprehensive Cancer Center, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland. · Boehringer Ingelheim, Paris, France. · Boehringer Ingelheim, Reims, France. · Pubmed 26596672
  • Mayo Clinic, Jacksonville, FL, USA. Electronic address: · Medical Oncology Clinic, Jules Bordet Institute, Brussels, Belgium. · Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, USA. · University of California, San Francisco, CA, USA. · University of Leeds and St James's University Hospital, Leeds, UK. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · The West Clinic, Memphis, TN, USA. · Institut Curie, Paris, France. · Sarah Cannon Research Institute, Nashville, TN, USA. · University of Minnesota Department of Medicine and Masonic Cancer Center, Minneapolis, MN, USA. · Centre Oscar Lambret, Lille, France. · Mayo Clinic, Jacksonville, FL, USA. · Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. · Nektar Therapeutics, San Francisco, CA, USA. · Sebastopol, CA, USA. · Vall d'Hebron Institute of Oncology, Barcelona, Spain; Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26482278
  • Department of Clinical Research, Institut Curie Paris & Saint Cloud, Paris · Centre René Gauducheau, Centre Régional de Lutte Contre le Cancer (CRLC) Nantes, Atlantique, France. · Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, USA. · Institut du Cancer de Montpellier (ICM), Montpellier, France. · The University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · Genentech, Inc., South San Francisco, USA. · Roche Product Development, Shanghai, China. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 26202594
  • Institut Curie, Paris, France. Electronic address: · University Hospital Leuven, Leuven, Belgium. Electronic address: · Medical University of Gdańsk, Gdańsk, Poland. Electronic address: · General Hospital Sint-Augustinus, Antwerp, Belgium. Electronic address: · Centre Léon Bérard, Lyon, France. Electronic address: · Helsinki University Central Hospital, Helsinki, Finland. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Institut Paoli-Calmettes, Marseilles, France. Electronic address: · C.R.L.C. Val D'Aurelle, Montpellier, France. Electronic address: · Levine Cancer Institute, Charlotte, NC, USA. Electronic address: · CHU Sart Tilman, Liege, Belgium. Electronic address: · Kidwai Memorial Institute of Oncology, Bangalore, India. Electronic address: · Institut Claudius Régaud, Toulouse, France. Electronic address: · Complejo Hospitalario de Jaén, Jaén, Spain. Electronic address: · European Health Centre Otwock, Warszawa, Poland. Electronic address: · Corporació Sanitària Parc Taulí, Sabadell, Spain. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · Amgen Inc., Thousand Oaks, CA, USA. Electronic address: · UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: · Pubmed 25747197
  • Department of Medical Oncology, Institut Curie, Paris, France. · Department of Clinical Research, Institut Curie, Paris, France; INSERM U900, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France; Department of Clinical Research, Institut Curie, Paris, France. · Department of Radiology, Institut Curie, Paris, France. · Department of Supportive Care, Institut Curie, Paris, France. · Department of Clinical Research, Institut Curie, Paris, France. · Department of Medical Oncology, Institut Curie, Paris, France; Circulating Tumor Biomarkers Laboratory, SIRIC, Institut Curie, Paris, France; University Paris Descartes, Paris, France. Electronic address: · Department of Medical Oncology, Institut Curie, Paris, France; Circulating Tumor Biomarkers Laboratory, SIRIC, Institut Curie, Paris, France. · Pubmed 25700777
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Department of Medicine, Duke University Medical Center, Durham. · Product Development, Oncology, Genentech, Inc., South San Francisco, USA. · Department of Medical Oncology and Breast Centre, Cantonal Hospital, St Gallen, Switzerland. · Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Biostatistics, Genentech, Inc., South San Francisco, USA. · Hematology, Medical Office, Aschaffenburg, Germany. · Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 25355722
  • Departments of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. · Departments of Medical Oncology, Institut Bergonié, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Departments of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France. Electronic address: · Pubmed 26387602
2014
  • Department of Clinical Research, Institut Curie, Paris, France, · Pubmed 23852665
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France; Université Paris Sud, le Kremlin Bicêtre, France. Electronic address: · Departement de Cancerologie Medicale, Université Lyon 1, Centre Léon Bérard, Lyon, France. · INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Institut de Cancérologie de l'Ouest/René Gauducheau, Nantes Saint Herblain, France. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; INSERM Unit U981, Institut Gustave Roussy, Villejuif, France. · Department of Medical Oncology, Institut Curie, Paris, France. · Institut Claudius Regaud, Department of Pathology, Toulouse, France. · Department of Translational Research, Institut Gustave Roussy, Villejuif, France. · Centre Léon Bérard, Lyon, France; Université Lyon 1, Lyon, France; ProfileXpert, SFR Lyon-Est, Lyon, France. · Department of Translational Research, Institut Curie, Paris, France. · Molecular Oncology Department, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France. · Department of Medical Oncology, Centre François Baclesse, Caen, France. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France. · Department of Medical Oncology, Centre Oscar Lambret, Lille, France. · Department of Medical Oncology, Centre Eugène Marquis, Rennes, France. · Research and Development Unit, UNICANCER, Paris, France. · Department of Biostatistics, Institut Claudius Regaud, Toulouse, France. · Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France. · Pubmed 24508104
  • Laboratory of preclinical investigation, Translational Research Department, Institut Curie, Paris, France. · Department of Tumor Biology, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France; INSERM U900, Paris, France. · Department of Genetics, Institut Curie, Paris, France. · Department of Biostatistics, Institut Curie, Paris, France. · Translational Research Department, Institut Curie, Paris, France. · AbbVie Biotherapeutics, Redwood City, California, United States of America. · Department of Oncogenetic, Institut Curie, Paris, France. · Laboratory of preclinical investigation, Translational Research Department, Institut Curie, Paris, France; Department of Oncogenetic, Institut Curie, Paris, France. · Pubmed 25375638
  • Véronique Diéras, Institut Curie, Paris, France · Nadia Harbeck, University of Munich, Munich, Germany · G. Thomas Budd, Cleveland Clinic, Lerner College of Medicine, Cleveland, OH · Joel K. Greenson, University of Michigan, Ann Arbor, MI · Ellie A. Guardino, Meghna Samant, Nataliya Chernyukhin, and Melanie C. Smitt, Genentech, South San Francisco, CA · and Ian E. Krop, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25024070
2011
  • Institut Curie, département d'oncologie médicale, unité d'investigation clinique, 25, rue d'Ulm, 75248 Paris Cedex 05, France. · Pubmed 21527366
2014
  • Authors' Affiliations: Research Oncology, Departments of Biostatistics, Product Development Oncology, and Translational Oncology, Genentech, Inc., South San Francisco, California; Indiana University Simon Cancer Center, Indianapolis, Indiana; Institute Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Curie, Paris, France; Sarah Cannon Research Institute, Nashville, Tennessee; Loyola University Medical Center, Maywood, Illinois; University of Munich, Munich, Germany; and Division of Medical Oncology, Centro di Riferimento Oncologico, Instituto Nazionale Tumori Aviano, Italy. · Pubmed 24097864
2013
  • Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005, Paris, France, · Pubmed 24043602
  • Department of Surgery, Institut Curie, Paris, France. · Pubmed 23526930
2012
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 21907436
  • Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 21642515
  • Département de chirurgie, Institut Curie, Paris, France. · Pubmed 22529987
  • Department of Medical Oncology, Institut Curie, 26 rue d’Ulm, Paris Cedex 05, France. · Pubmed 21358298
2011
  • Institut Curie, département d’oncologie-radiothérapie, 26, rue d’Ulm, 75005 Paris, France. · Pubmed 21527365
  • Institut Curie, département d'oncologie médicale, 26, rue d'Ulm, 75005 Paris, France. · Pubmed 21543285
  • Department of Radiation Oncology, Institut Curie, Paris, France. · Pubmed 20932686
  • Department of Medical Oncology, Institut Curie, Paris, France. · Pubmed 20924076
Miscellaneous institutions in Rennes
2019
  • Department of Medicine (Hematology/Oncology), University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero St, 2nd Floor, San Francisco, CA, 94115, USA. · Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Santa Monica, CA, USA. · Department of Medical Oncology, Institut Curie, Paris, France. · Centre Eugène Marquis, Rennes, France. · Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universität München, Munich, Germany. · Republican Clinical Oncology Dispensary, State Budget Medical Institution, Ufa, Russia. · Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada. · Department of Obstetrics and Gynecology, Brustzentrum der Universität München (LMU), Munich, Germany. · Breast Cancer Center, Memorial Cancer Institute, Hollywood, FL, USA. · Patient and Health Impact, Pfizer Inc, New York, NY, USA. · Clinical Statistics, Pfizer Inc, La Jolla, CA, USA. · Global Product Development, Clinical, Pfizer S.r.l, Milan, Italy. · Global Product Development, Clinical, Pfizer Inc, San Francisco, CA, USA. · Global Product Development, Clinical, Pfizer Inc, Collegeville, PA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 30632023
2018
  • Department of Medical Oncology, Acıbadem University School of Medicine, Istanbul, Turkey. Electronic address: · Cancer Research UK Clinical Centre, St James' University Hospital, Leeds, UK. Electronic address: · Center Eugène Marquis, Rennes, France. Electronic address: · Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain; Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: · Medical Oncology Clinic, Institut Jules Bordet Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: · Pubmed 29329006
Unspecified
2018
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
2016
  • From the Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Santa Monica (R.S.F., D.J.S.) · the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco (H.S.R.) · and Pfizer, La Jolla (E.G., D.R.L., S.R.) - all in California · Hospital Gregorio Maranon, Universidad Complutense, Madrid (M.M.) · U.S. Oncology Research, The Woodlands, TX (S.J.) · Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · British Columbia Cancer Agency, Vancouver, Canada (K.G.) · Brustzentrum der Universität München (LMU), Munich, Germany (N.H.) · State Budget Medical Institution Republican Clinical Oncology, Ufa, Russia (O.N.L.) · All-Ireland Cooperative Oncology Research Group, Dublin (J.M.W.) · M.D. Anderson Cancer Center, University of Texas, Houston (S.M.) · and Institut Curie, Paris (V.D.). · Pubmed 27959613
  • Department of Medical Oncology, Centre Léon Bérard, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice. · Department of Medical Oncology, Clinique de la Sauvegarde, Lyon. · Direction of Clinical Research and Innovation, Centre Léon Bérard, Lyon. · Department of Medical Oncology, Centre Hospitalier de Senlis, Senlis. · Department of Medical Oncology, Hôpital Mont-De-Marsan, Mont-De-Marsan. · Department of Medical Oncology, CHU Dupuytren, Limoges. · Department of Medical Oncology, Institut Curie, Paris. · Department of Medical Oncology, Hôpital Privé Jean Mermoz, Lyon. · Department of Medical Oncology, Hôpitaux Drôme Nord, Site de Romans, Romans-sur-Isère. · Department of Medical Oncology, Hôpital Fleyriat, Bourg-en Bresse. · Department of Medical Oncology, Centre Hospitalier de la Région d'Annecy, Pringy. · Department of Medical Oncology, Institut Jean Godinot, Reims. · Department of Medical Oncology, Clinique de l'Union, Saint-Jean. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg. · Department of Medical Oncology, Centre Hospitalier la Dracénie, Draguignan. · Department of Medical Oncology, Oracle, Centre d'Oncologie de Gentilly, Nancy. · Department of Medical Oncology, Centre Hospitalier Bretagne Atlantique, Vannes. · Université Paris Descartes, AP-HP, Hôpitaux Universitaires Paris Centre, Site Hôtel-Dieu, Paris, France. · Department of Medical Oncology, Centre Léon Bérard, Lyon CNRS UMR5286, Cancer Research Center of Lyon, Lyon · Pubmed 26916095
  • Department of Cancer Medicine, Institut Gustave Roussy, Villejuif · Department of Biostatistics, Centre Léon Bérard, Lyon. · Department of Research and Development, R&D Unicancer, Paris. · Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud. · Department of Medical Oncology, Institut Bergonié, Bordeaux. · Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes and Angers. · Department of Medical Oncology, Centre François Baclesse, Caen. · Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier. · Department of Medical Oncology, Centre Georges François Leclerc, Dijon. · Department of Medical Oncology, Centre Henri Becquerel, Rouen. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse. · Department of Medical Oncology, Centre Antoine Lacassagne, Nice. · Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy. · Department of Medical Oncology, Centre Eugène Marquis, Rennes. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille. · Department of Medical Oncology, Centre Jean Perrin, Clermont Ferrand. · Department of Medical Oncology, Centre Paul Strauss, Strasbourg. · Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims. · Department of Medical Oncology, Centre Oscar Lambret, Lille. · Capionis, Paris, France. · Pubmed 27436849
2014
  • Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN · Reshma L. Mahtani, Sylvester Comprehensive Cancer Center, Miami, FL · Kathy S. Albain, Loyola University Chicago Stritch School of Medicine, Maywood, IL · Liang Fang, Glenn Michelson, Genentech, South San Francisco, CA · Howard A. Burris, Sarah Cannon Research Institute, Nashville, TN · Véronique Diéras, Institut Curie, Paris · Fabrice Andre, Institut Gustave Roussy, Villejuif, France · Nadia Harbeck, Interdisciplinary Breast Cancer, University of Cologne, Cologne · Nadia Harbeck, Breast Cancer University of Munich, Germany · Luca Gianni, San Raffaele Hospital, Milan · Diana Crivellari, Centro di Riferimento Oncologico, Istituto Nazionale Tumori, Aviano, Italy · Sanne L. de Haas, F. Hoffmann-La Roche, Basel, Switzerland. · Pubmed 24733796
Miscellaneous institutions in Paris
2018
  • National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany. · Department of Obstetrics and Gynecology, Division of Gynecological Oncology and Clinical Research Center, Hannover Medical School, Hannover, Germany. · Department of Medical Oncology, Hospital del Mar, CIBERONC, Barcelona, Spain. · Rigshospitalet, Copenhagen, Denmark. · Ramon y Cajal University Hospital, Madrid, Spain. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Medical Oncology, Institute Curie, Paris, France. · Department of Medical Oncology, Biomedical Health Research Institute INCLIVA, University of Valencia, Valencia and CIBERONC, Institute of Health Carlos III, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany. · Departments of Clinical Research Unit and Medical Oncology, Centre François Baclesse, Caen, France. · Pharma Research and Early Development (pRED), Roche Innovation Center Basel, Basel, Switzerland. · Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany. · Pharma Research and Early Development (pRED), Roche Innovation Center Welwyn, Welwyn Garden City, UK. · A4P Consulting Ltd, Sandwich, UK. · Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany. · Pubmed 29349598
Sorbonne University
2017
  • Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France. · Institut Curie, Unit of Biometry, PSL Research University, INSERM U900, Paris, France. · Department of Anesthesiology, Institut Curie, PSL Research University, Paris, France. · Université Paris Descartes, Paris, France. · Pubmed 28779538
  • Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France · Department of Medical Oncology, Curie Institute, PSL Research University, Paris, France. · Biostatistics Unit, Curie Institute, PSL Research University, Paris, France. · INSERM U900, Curie Institute, PSL Research University, Paris, France. · Pharmacy Department, Curie Institute, PSL Research University, Paris, France. · Descartes University Paris, Paris, France. · Pubmed 28314310
2016
  • Genetics Department, Institut Curie, PSL Research University, Paris, France. · Faculty of Pharmacy, Aleppo University, Aleppo, Syria. · Translational Research Department, Institut Curie, PSL Research University, Paris, France. · BioPôle Alfort, National Veterinary School of Alfort, Maisons Alfort, France. · INRA, PHASE Department, Paris, France. · Medical Oncology Department, Institut Curie, PSL Research University, Paris, France. · Surgery Department, Institut Curie, PSL Research University, Paris, France. · AstraZeneca R&D Cambr idge, CRUK Cambridge Institute, Cambridge, UK. · EA7331, University of Paris Descartes, Paris, France. · Pubmed 27374081
2014
  • Authors' Affiliations: Research Oncology, Departments of Biostatistics, Product Development Oncology, and Translational Oncology, Genentech, Inc., South San Francisco, California; Indiana University Simon Cancer Center, Indianapolis, Indiana; Institute Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Curie, Paris, France; Sarah Cannon Research Institute, Nashville, Tennessee; Loyola University Medical Center, Maywood, Illinois; University of Munich, Munich, Germany; and Division of Medical Oncology, Centro di Riferimento Oncologico, Instituto Nazionale Tumori Aviano, Italy. · Pubmed 24097864
Institut Gustave Roussy
2016
  • CNRS, UMR 7292, « Genetics, Immunotherapy, Chemistry and Cancer », Université François Rabelais de Tours, Tours. · CHRU de Tours, Clinique d'Oncologie et de Radiothérapie, Tours. · Department of Medical Oncology/Cancer Research Center UMR-INSERM, U892/CNRS 6299/Bioinformatics Unit, Institut de Cancérologie de l'Ouest, Nantes. · Faculté de Pharmacie, Université de Lorraine, Nancy. · CNRS UMR7039 CRAN, Vandoeuvre les Nancy. · Service de Biopathologie, Institut de Cancérologie de Lorraine, Vandoeuvre les Nancy. · CHRU de Tours, Service d'Immunologie, Tours. · Department of Medical Oncology, Centre Léon Bérard, INSERM U1052, Lyon. · Department of Radiopharmacology, Institut Curie-René Huguenin Hospital, Saint-Cloud. · Department of Medical Oncology, Gustave Roussy, Villejuif. · R&D Unicancer, UNICANCER, Paris. · CHRU de Tours, Laboratoire de Pharmacologie-Toxicologie, Tours, France. · Pubmed 26714164
2014
  • Authors' Affiliations: Research Oncology, Departments of Biostatistics, Product Development Oncology, and Translational Oncology, Genentech, Inc., South San Francisco, California; Indiana University Simon Cancer Center, Indianapolis, Indiana; Institute Gustave Roussy, Villejuif; Department of Medical Oncology, Institut Curie, Paris, France; Sarah Cannon Research Institute, Nashville, Tennessee; Loyola University Medical Center, Maywood, Illinois; University of Munich, Munich, Germany; and Division of Medical Oncology, Centro di Riferimento Oncologico, Instituto Nazionale Tumori Aviano, Italy. · Pubmed 24097864
20 Other Locations Show
Yearly article counts 1913988106900
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.